Bruker Given Average Rating of “Buy” by Brokerages (NASDAQ:BRKR)
Bruker (NASDAQ:BRKR) has been given an average rating of “Buy” by the fifteen brokerages that are presently covering the company, AmericanBankingNews.com reports. Five analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $23.95.
A number of research firms have recently commented on BRKR. Analysts at Zacks upgraded shares of Bruker from an “underperform” rating to a “neutral” rating in a research note on Thursday. They now have a $23.00 price target on the stock. Separately, analysts at Jefferies Group raised their price target on shares of Bruker from $24.00 to $27.00 in a research note on Wednesday. Finally, analysts at UBS AG raised their price target on shares of Bruker from $23.00 to $25.00 in a research note on Wednesday.
Bruker (NASDAQ:BRKR) traded down 0.58% during mid-day trading on Friday, hitting $22.38. 395,299 shares of the company’s stock traded hands. Bruker has a one year low of $15.41 and a one year high of $23.71. The stock’s 50-day moving average is $20.67 and its 200-day moving average is $20.03. The company has a market cap of $3.742 billion and a price-to-earnings ratio of 66.21.
Bruker (NASDAQ:BRKR) last issued its quarterly earnings data on Tuesday, February 18th. The company reported $0.31 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.22 by $0.09. The company had revenue of $552.10 million for the quarter, compared to the consensus estimate of $452.14 million. Analysts expect that Bruker will post $0.88 EPS for the current fiscal year.
Bruker Corporation (NASDAQ:BRKR) is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.